Syndax

$Syndax(SNDX)$
摘要：
Syndax Pharmaceuticals已成功转型为一家拥有双引擎驱动的商业化阶段肿瘤生物制药公司。其核心资产—首创口服menin抑制剂Revuforj (revumenib) 和首创CSF-1R抑制剂Niktimvo (axatilimab) —均已获得FDA批准上市，并展现出成为各自领域“重磅炸弹”级药物的明确潜力...

$Syndax(SNDX)$ 这家公司年销售额超三亿多美元，然后公司市值才17亿美元，110亿人民币左右，这么看国内那些公司的估值不低啊

$Syndax(SNDX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-000771  Act: 33  Size: 5 KB 网页链接

$Syndax(SNDX)$ 道富银行公司（State Street Corporation）持有Sybdax Pharmaceuticals Inc. 5.3%的普通股，已提交了13G表格。该文件显示，道富银行公司实益拥有4,596,552股，对4,341,322股拥有共同投票权，并对全部4,596,552股拥有共同处置权。这些证券是在正常业务过程中获得和持有的，并非为了...

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-041167  Size: 4 KB 网页链接

$Syndax(SNDX)$ 8-K Current report, items 2.02 and 7.01 Accession Number: 0001193125-26-010486  Act: 34  Size: 225 KB 网页链接

$Syndax(SNDX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-26-076522  Act: 34  Size: 8 MB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-041344  Size: 4 KB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-041412  Size: 4 KB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-041334  Size: 9 KB 网页链接

$Syndax(SNDX)$ 144 Report of proposed sale of securities Accession Number: 0001959173-26-000773  Act: 33  Size: 5 KB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-041497  Size: 12 KB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-041194  Size: 4 KB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-043813  Size: 4 KB 网页链接

$Syndax(SNDX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-002306  Act: 34  Size: 7 KB 网页链接

$Syndax(SNDX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000093751-26-000090  Act: 34  Size: 8 KB 网页链接

$Syndax(SNDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-043814  Size: 4 KB 网页链接

$Syndax(SNDX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000252  Act: 34  Size: 7 KB 网页链接

$Syndax(SNDX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-26-076536  Act: 34  Size: 16 MB 网页链接

$Syndax(SNDX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-26-076822  Act: 33  Size: 303 KB 网页链接